Tarsus Pharmaceuticals Inc. (TARS)
Market Closed
10 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
61. 27
-0.28
-0.4549%
Pre Market
$
+5.23 +8.536% 66. 50
2.6B Market Cap
- P/E Ratio
- Div Yield
262,525 Volume
-4.18 Eps
$ 61.55
Previous Close Investors:
Want to track TARS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Tarsus Pharmaceuticals Inc. (TARS) Statistics
Valuation metrics
Market Cap 2.6B
Enterprise value 2.54B
Trailing P/E (ttm) -52.76
Forward P/E -
PEG ratio -0.52
Price/Sales (ttm) 4.77
Price/Book (mrq) 7.3
Enterprise Value/Revenue 4.74
Enterprise Value/EBITDA -64.86
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 735.91K
Average volume (90 days) 618.73K
Price summary
52-Week low 38.51
52-Week high 85.25
Beta -
50-Day moving average 62.15
200-Day moving average 70.31
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.09%
Operating margin -0.09%
Operational effectiveness
Return on assets -0.08%
Return on equity -0.14%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 12.46
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.12
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.05
Total debt (mrq) -
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 3.74%
Book value per share (mrq) 8.12
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
